choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Prostate Cancer & Zytiga

Prostate Cancer & Zytiga Newsletter
  • Lower dose of abiraterone shows comparable efficacy to standard dose for prostate cancer 29 Jul 2025 22:54 GMT

    … of abiraterone acetate (AA; Zytiga; 500 mg) demonstrated … and safer treatment for prostate cancer patients, with minimal … patients with castration-resistant prostate cancer (CRPC). However, the … acetate as effective for prostate cancer treatment. News release. …

  • Metformin Fails to Improve Survival in Metastatic Hormone-Sensitive Prostate Cancer 28 Jul 2025 19:41 GMT

    … patients with metastatic hormone-sensitive prostate cancer (mHSPC) did not … (ARPI) such as abiraterone (Zytiga), enzalutamide (Xtandi), or apalutamide … Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: …

  • Carotuximab Combo Proves Safe for Advanced Prostate Cancer 16 Jul 2025 15:56 GMT

    … a history of castration-resistant prostate cancer with rising prostate-specific … signaling inhibitor (ARSI), such as Zytiga (abiraterone), Xtandi (enzalutamide), or … the news release. Castration-resistant prostate cancer refers to disease that progresses …

  • Identifying Patients Who Will Benefit From Intensified Prostate Cancer Treatment 12 Jul 2025 14:00 GMT

    … drug called Zytiga. Zytiga is approved for use in metastatic prostate cancer — prostate cancer that … prostate cancer, how has the timing and duration of treatments like Zytiga … understand which individuals with prostate cancer truly benefit from additional …

  • Erleada May Be a New Standard of Care for Some With Prostate Cancer 10 Jul 2025 22:57 GMT

    … treatments for metastatic castration-sensitive prostate cancer; [however], recent real-world data … patients already on Xtandi or Zytiga (abiraterone acetate), should these … choice between Erleada, Xtandi and Zytiga? Side effect profiles differ across …

  • Understanding the Risk of Overtreatment in Prostate Cancer 07 Jul 2025 14:42 GMT

    … high-risk, non-metastatic prostate cancer significantly reduced the risk of … which patients with high-risk prostate cancer will truly benefit from … drug called Zytiga. Zytiga is approved for use in metastatic prostate cancer — prostate cancer that has …

  • J&J eyes prostate cancer label expansion for Akeega 07 Jul 2025 12:08 GMT

    … metastatic castration-resistant prostate cancer (mCRPC) in … ;J’s prostate cancer previous blockbuster Zytiga (abiraterone acetate … Despite significant progress in prostate cancer, individuals with HRR … competition in the prostate cancer treatment landscape. …

  • J&J bids to extend prostate cancer uses for Akeega 07 Jul 2025 09:57 GMT

    … a new indication in prostate cancer that could broaden … treat metastatic castration-resistant prostate cancer (mCRPC), but J … with metastatic castration-sensitive prostate cancer (mCSPC), thanks to … prostate cancer, and views the drug as a successor to Zytiga …

  • Upfront Combos Show Promise in Prostate Cancer, But Questions Remain 27 Jun 2025 18:00 GMT

    … (Zytiga) plus prednisone for the treatment of metastatic castration-sensitive prostate cancer fitting …

  • Genomic test can predict resistance to chemotherapy in prostate cancer 26 Jun 2025 19:16 GMT

    … types, including metastatic prostate cancer.1 “It was … 840 patients with metastatic prostate cancer, ovarian cancer, sarcoma … cancer. The metastatic prostate cancer cohort consisted of … the cohort (abiraterone acetate [Zytiga], enzalutamide [Xtandi], olaparib …

Satisfied with the content?

Continue to create your account.